ResMed Inc (RMD)
211.54
-4.62
(-2.14%)
USD |
NYSE |
May 08, 11:54
ResMed Research and Development Expense (Quarterly): 77.07M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 77.07M |
| December 31, 2023 | 73.88M |
| September 30, 2023 | 75.71M |
| June 30, 2023 | 78.14M |
| March 31, 2023 | 76.44M |
| December 31, 2022 | 69.87M |
| September 30, 2022 | 63.19M |
| June 30, 2022 | 64.32M |
| March 31, 2022 | 66.80M |
| December 31, 2021 | 62.51M |
| September 30, 2021 | 59.95M |
| June 30, 2021 | 59.88M |
| March 31, 2021 | 55.94M |
| December 31, 2020 | 54.94M |
| September 30, 2020 | 54.53M |
| June 30, 2020 | 52.52M |
| March 31, 2020 | 51.45M |
| December 31, 2019 | 49.94M |
| September 30, 2019 | 48.03M |
| June 30, 2019 | 51.14M |
| March 31, 2019 | 47.61M |
| December 31, 2018 | 43.11M |
| September 30, 2018 | 38.79M |
| June 30, 2018 | 39.66M |
| March 31, 2018 | 37.43M |
| Date | Value |
|---|---|
| December 31, 2017 | 40.64M |
| September 30, 2017 | 37.42M |
| June 30, 2017 | 36.71M |
| March 31, 2017 | 35.13M |
| December 31, 2016 | 38.19M |
| September 30, 2016 | 34.45M |
| June 30, 2016 | 34.38M |
| March 31, 2016 | 28.11M |
| December 31, 2015 | 28.97M |
| September 30, 2015 | 27.19M |
| June 30, 2015 | 28.52M |
| March 31, 2015 | 27.02M |
| December 31, 2014 | 29.29M |
| September 30, 2014 | 30.02M |
| June 30, 2014 | 31.80M |
| March 31, 2014 | 29.53M |
| December 31, 2013 | 29.54M |
| September 30, 2013 | 27.36M |
| June 30, 2013 | 31.39M |
| March 31, 2013 | 31.19M |
| December 31, 2012 | 30.33M |
| September 30, 2012 | 27.22M |
| June 30, 2012 | 27.91M |
| March 31, 2012 | 28.40M |
| December 31, 2011 | 27.22M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
48.03M
Minimum
Sep 2019
78.14M
Maximum
Jun 2023
62.31M
Average
61.23M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 366.00M |
| Align Technology Inc | 91.86M |
| Stryker Corp | 368.00M |
| Integer Holdings Corp | 15.75M |
| Insulet Corp | 42.00M |